The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((2,3-dibromo-6-hydroxy-5-methoxybenzyl)amino)-1H-benzo[d]imidazol-2(3H)-one ID: ALA3335247
PubChem CID: 118714336
Max Phase: Preclinical
Molecular Formula: C15H13Br2N3O3
Molecular Weight: 443.10
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Br)c(Br)c(CNc2ccc3[nH]c(=O)[nH]c3c2)c1O
Standard InChI: InChI=1S/C15H13Br2N3O3/c1-23-12-5-9(16)13(17)8(14(12)21)6-18-7-2-3-10-11(4-7)20-15(22)19-10/h2-5,18,21H,6H2,1H3,(H2,19,20,22)
Standard InChI Key: SXXYVASCWIOPRU-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.4336 -3.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4325 -4.1172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1405 -4.5261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8502 -4.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8474 -3.2940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1388 -2.8888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5535 -2.8828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2628 -3.2887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9689 -2.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6766 -3.2867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6654 -1.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9627 -2.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3797 -2.0581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3817 -2.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1574 -3.1230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6348 -2.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1541 -1.8044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4520 -2.4604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5586 -4.5242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1403 -5.3433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8480 -5.7521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7258 -2.8892 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
3.1363 -2.0716 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 14 1 0
13 11 1 0
11 12 2 0
12 9 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
16 18 2 0
4 19 1 0
3 20 1 0
20 21 1 0
1 22 1 0
6 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 443.10Molecular Weight (Monoisotopic): 440.9324AlogP: 3.71#Rotatable Bonds: 4Polar Surface Area: 90.14Molecular Species: NEUTRALHBA: 4HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.56CX Basic pKa: 3.33CX LogP: 3.42CX LogD: 3.39Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.50Np Likeness Score: -0.56
References 1. Shim HJ, Yang HR, Kim HIe, Kang SA, No KT, Jung YH, Lee ST.. (2014) Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6., 24 (19): [PMID:25205190 ] [10.1016/j.bmcl.2014.08.036 ]